CHAPTER 10 Hepatitis on Dialysis

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

CHAPTER 7: Nutritional Status on Dialysis Abdul Halim B Abd Gafor Winnie Chee Siew Swee Tilakavati Karupaiah Koh Keng Hee Ahmad Fauzi B Abd Rahman Source:
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Modal Class Exercise. The masses, in grams, of 100 potatoes are shown in the table below: Mass (m) gramsFrequency 0 < m  < m  < m 
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Lily Mushahar Anita Bhajan Manocha Source: 20 th MDTR Report 2012, NRR.
Chapter 4: Quality of life and rehabilitation outcomes of patients on Dialysis Liu Wen Jiun Chew Thian Fook Christopher Lim Thiam Seong Tan Wee Ming Yia.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
CHAPTER 5: PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail Source: 21 st MDTR.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 21 st MDTR Report 2013, NRR.
CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.
CHAPTER 1: ALL RENAL REPLACEMENT THERAPY IN MALAYSIA Lim Yam Ngo Ong Loke Meng Goh Bak Leong Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
CHAPTER 6: MANAGEMENT OF ANAEMIA IN PATIENTS ON DIALYSIS Philip N. Jeremiah Bee Boon Cheak Ghazali B Ahmad Lim Soo Kun Zawawi B Nordin Source: 21 st MDTR.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
CHAPTER 9: Chronic Kidney Disease – Mineral and Bone DisorderKok Lai Sun Ching Chen Hua Fan Kin Sing Rozina Ghazalli Liew Yew Fong Source: 21 st MDTR Report.
UK Renal Registry 17th Annual Report Figure Box and whisker plot of renal centres’ MRSA rates per 100 dialysis patient years by reporting year.
CHAPTER 8: Blood Pressure Control and Dyslipidaemia in Patients on Dialysis S. Prasad Menon Hooi Lai Seong Lee Wan Tin Sunita Bavanandan Source: 21 st.
CHAPTER 11 Haemodialysis Practices Tan Chwee Choon Shahnaz Shah Firdaus Khan Rafidah Abdullah Norleen Bt Zulkarnain Sim Source: 20 th MDTR Report 2012,
CHAPTER 13 Renal Transplantation Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan Rosnawati Yahya S. Prasad Menon Tan Si Yen Wong Hin Seng Source:
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
Chapter 1 ALL RENAL REPLACEMENT THERAPY IN MALAYSIA
MANAGEMENT OF ANAEMIA IN PATIENTS ON DIALYSIS Philip N. Jeremiah Bee Boon Cheak Ghazali B Ahmad Lim Soo Kun Zawawi B Nordin Source: 20 th MDTR Report 2012,
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
CHAPTER 8: BLOOD PRESSURE CONTROL AND DYSLIPIDAEMIA S. Prasad Menon Hooi Lai Seong Lee Wan Tin Sunita Bavanandan Source: 20 th MDTR Report 2012, NRR.
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
UK Renal Registry 18th Annual Report
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
First-year death rates by modality figure 8
UK Renal Registry 15th Annual Report
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 19th Annual Report
CHAPTER 5 Paediatric Renal Replacement Therapy
Table 4.1: Cumulative distribution of QoL-Index score in relation to dialysis modality, all dialysis patients
CHAPTER 7 Nutritional Status on Dialysis
CHAPTER 11: Haemodialysis Practices
CHAPTER 3 Death and Survival on Dialysis
CHAPTER 1 All Renal Replacement Therapy In Malaysia
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Coding in the form y = a + bx
UK Renal Registry 13th Annual Report
CHAPTER 9 Chronic Kidney Disease – Mineral and Bone Disorder
Christopher Lim Thiam Seong
CHAPTER 10 Hepatitis on Dialysis
UK Renal Registry 14th Annual Report
Figure 11-1.
Box and Whisker Plots A.K.A Box Plots.
UK Renal Registry 16th Annual Report
2013 Annual Report - 36th Edition
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
UK Renal Registry 14th Annual Report
Chapter 7 Nutritional status on dialysis
The 9 times table! The 10 times table Click your way
UK Renal Registry 16th Annual Report
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Chapter 1 Functions.
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Presentation transcript:

CHAPTER 10 Hepatitis on Dialysis Teo Sue Mei Clare Tan Hui Hong Chow Yok Wai T. Thiruventhiran Source: 21st MDTR Report 2013, NRR

Prevalence of HBsAg+ (%) Prevalence of Anti-HCV+ (%) Table 10.1: Prevalence of positive HBsAg and positive Anti-HCV at annual survey, HD patients 2004-2013 Year Number of patients Prevalence of HBsAg+ (%) Prevalence of Anti-HCV+ (%) 2004 7617 5 17 2005 8956 4 14 2006 11294 12 2007 12496 11 2008 14955 9 2009 17361 8 2010 18829 7 2011 21647 6 2012 24891 2013 27911 Source: 21st MDTR Report 2013, NRR

Prevalence of HBsAg+ (%) Prevalence of Anti-HCV+ (%) Table 10.2: Prevalence of positive HBsAg and positive Anti-HCV at annual survey, PD patients 2004-2013 Year Number of patients Prevalence of HBsAg+ (%) Prevalence of Anti-HCV+ (%) 2004 1200 4 5 2005 1318 2006 1494 2007 1731 2008 2017 3 2009 2144 2010 2280 2011 2461 2012 2794 2 2013 3161 Source: 21st MDTR Report 2013, NRR

Table 10.3: Variation in Proportion of patients with positive HBsAg at annual survey among HD centres, 2004-2013 Year Number of centres Min 5th Centile LQ Median UQ 95th Centile Max 2004 211 3 8 15 56 2005 237 2 7 60 2006 288 1.5 16 80 2007 318 14 57 2008 367 6 12 2009 415 5 13 71 2010 451 93 2011 507 4 100 2012 563 2013 607 Source: 21st MDTR Report 2013, NRR

Figure 10.3: Variation in proportion of patients with positive HBsAg among HD centres, 2013 Source: 21st MDTR Report 2013, NRR

Table 10.4: Variation in proportion of patients with positive HBsAg at annual survey among PD centres, 2004-2013 Year Number of centres Min 5th Centile LQ Median UQ 95th Centile Max 2004 18 2 3.5 5 11 2005 19 3 10 2006 22 4.5 6 7 13 2007 4 8 2008 24 1.5 2009 25 1 2010 2011 27 23 2012 28 2013 Source: 21st MDTR Report 2013, NRR

Figure 10.4: Variation in proportion of patients with positive HBsAg among PD centres, 2013 Source: 21st MDTR Report 2013, NRR

Table 10.5: Variation in proportion of patients with positive anti-HCV at annual survey among HD centres, 2004-2013 Year Number of centre Min 5th centile LQ Median UQ 95th centile Max 2004 214 4 12 25 50 100 2005 238 2 10 21 39 2006 286 8 18 41 2007 317 7 15 36 2008 367 5 13 29 2009 416 3 27 2010 451 9 23 93 2011 507 20 95 2012 564 6 19 2013 603 17 Source: 21st MDTR Report 2013, NRR

Figure 10.5: Variation in proportion of patients with positive anti-HCV among HD centres, 2013 Source: 21st MDTR Report 2013, NRR

Table 10.6: Variation in proportion of patients with positive anti-HCV at annual survey among PD centres, 2004-2013 Year Number of centre Min 5th centile LQ Median UQ 95th centile Max 2004 18 1 4.5 7 10 2005 19 2 4 8 11 2006 22 3 6 2007 2.5 9 2008 24 3.5 5 2009 25 20 2010 2011 26 1.5 12 15 2012 28 2013 Source: 21st MDTR Report 2013, NRR

Figure 10.6: Variation in proportion of patients with positive anti-HCV among PD centres, 2013 Source: 21st MDTR Report 2013, NRR

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.